Zobrazeno 1 - 10
of 331
pro vyhledávání: '"HCV recurrence"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Francesca Romana Ponziani, Alessandro Milani, Antonio Gasbarrini, Raffaella Zaccaria, Raffaella Viganò, Maria Francesca Donato, Maria Cristina Morelli, Lucia Miglioresi, Luisa Pasulo, Maria Rendina, Daniele Di Paolo, Maria Marino, Pierluigi Toniutto, Stefano Fagiuoli, Maurizio Pompili
Publikováno v:
Annals of Hepatology, Vol 11, Iss 3, Pp 338-342 (2012)
Introduction. Hepatitis C virus genotype 4 is predominant in the Middle East and Northern Africa, even if it has recently spread to Southern Europe. Data about the treatment of post-liver transplantation (LT) genotype 4 hepatitis C recurrence are sca
Externí odkaz:
https://doaj.org/article/ec75623fb42740edb0029e0dc37cf7c6
Autor:
Robert A. Fisher, Adrian H. Cotterell, Daniel G. Maluf, Richard Todd Stravitz, April Ashworth, Mitsuru Nakatsuka, Richard K. Sterling, Velimir A. Luketic, Martha K. Behnke, Marc P. Posner
Publikováno v:
Annals of Hepatology, Vol 8, Iss 4, Pp 298-307 (2009)
It has been 4 years since the first, long-term (> 3 years) prospective comparison of adult-to-adult living donor liver transplantation (A2ALLTx) to adult deceased donor liver transplantation (ADDLTx) was reported.1 In this follow up, prospective, IRB
Externí odkaz:
https://doaj.org/article/248410db1361418f98cbbcabcb0cf13d
Autor:
Ibrahim A Naqid, Brisk H Rashad, Abdullah S. Abdullah, Haval M Salih, Nawfal R Hussein, Halat S. Majed, Basheer A Abdi, Ferhad Mr Ahmed
Publikováno v:
Avicenna Journal of Clinical Microbiology and Infection, Vol 7, Iss 3, Pp 72-74 (2020)
Background: Hepatitis C virus (HCV) is a public health issue. Successful treatment of HCV infection results in sustained virologic response (SVR) in the majority of subjects. Subsequent recurrence of HCV, either from late relapse or reinfection, may
Autor:
Bayraktar, Sandra
Zusammenfassung Einleitung: Die Behandlung der HCV-Reinfektion nach Lebertransplantation hat sich in den vergangenen Jahren dynamisch entwickelt. Ziel ist die Elimination des Hepatitis-C-Virus, um eine progrediente Reinfektionshepatitis und damit die
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcee2af0a48b090e40131a751582a77e
Publikováno v:
Journal of public health management and practice : JPHMP. 28(2)
The introduction of direct-acting antivirals for treating hepatitis C virus (HCV) infection has greatly improved cure rates. However, persons with past HCV infection who engage in high-risk behaviors can be reinfected. Surveillance data from the New
Autor:
Burra, P, Belli, L, Ginanni, Corradini, S, Volpes, R, Marzioni, M, Giannini, E, Toniutto, P, Carrai, P, Donato, F, Lanza-Galeota, A, Martini, S, Pasulo, L, Ponziani, F, Russo, F, Coppola, C, Forte, P, Mazzarelli, C, Merli, M, Montalbano, M, Picciotto, F, Rendina, M, Zanetto, A, Angeli, P, Foschi, F, Manini, M, Marzano, A, Perricone, G, Pianta, P, Tamè, M, De Maria, N, Domenicali, M, Ottobrelli, A, Picciotto, A, Ponti, L, Vizzini, G, Corradini, S, Bhoori, S, Ferri, F, Gaffuri, G, Lenci, I, Mameli, L, Morelli, M, Piras, M. R.
Publikováno v:
Digestive and Liver Disease. 49:241-253
The present document contains the recommendations of an expert panel of transplant hepatologists, appointed by the Italian Association for the Study of the Liver (AISF), on how to manage the most common aspects of liver transplantation: the topics co
Autor:
Géraldine Dahlqvist, Nadira Delhem, Lynda Aoudjehane, Khaldoun Ghazal, Olivier Morales, Clément Barjon, L. Ouaguia, Filomena Conti
Publikováno v:
Clinics and Research in Hepatology and Gastroenterology
Clinics and Research in Hepatology and Gastroenterology, Elsevier, 2019, 43, pp.273-281. ⟨10.1016/j.clinre.2018.10.005⟩
Clinics and research in hepatology and gastroenterology, Vol. 43, no.3, p. 273-281 (2019)
Clinics and Research in Hepatology and Gastroenterology, 2019, 43, pp.273-281. ⟨10.1016/j.clinre.2018.10.005⟩
Clinics and Research in Hepatology and Gastroenterology, Elsevier, 2019, 43, pp.273-281. ⟨10.1016/j.clinre.2018.10.005⟩
Clinics and research in hepatology and gastroenterology, Vol. 43, no.3, p. 273-281 (2019)
Clinics and Research in Hepatology and Gastroenterology, 2019, 43, pp.273-281. ⟨10.1016/j.clinre.2018.10.005⟩
Summary Background Immune response failure against hepatitis C virus (HCV) has been associated with an increased regulatory T cell (Treg) activity. After liver transplantation (LT), 80% of patients experience an accelerated progression of hepatitis C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::062a5d10aa7ad4925f5bcd2480a61b7b
https://hal.archives-ouvertes.fr/hal-03486274/document
https://hal.archives-ouvertes.fr/hal-03486274/document
Autor:
Dominic Dell Olio, Paola Magistroni, Antonio Amoroso, Francesca Bertinetto, Silvia Martini, Ennia Dametto, Mario Rizzetto, Francesco Tandoi, Mauro Salizzoni, Renato Romagnoli
Publikováno v:
Transplant International. 29:1070-1084
Summary HLA and IL-28B genes were independently associated with severity of HCV-related liver disease. We investigated the effects of these combined genetic factors on post-transplant survival in HCV-infected recipients, aiming to provide new data to
Autor:
Marion G. Peters, Vhics Study Team, Roy M. Matining, David L. Wyles, Robert L. Murphy, Minhee Kang
Publikováno v:
Open Forum Infectious Diseases
Hepatitis C virus (HCV) recurrence rates were similar between those with HCV/HIV co-infection (0.35/100 person-years) and HCV infection (0.42/100 person-years). Low rates of recurrence likely represent enrollment of an HIV population at low risk for